arrow
C

Cecilia T. Costiniuk

mcgill university health centre
H指数:30
被引数:3,677

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Migration pathways and HIV care Cascade among newly enrolled adult patients in a tertiary clinic in Montréal, Canada

蒙特利尔(加拿大)三级诊所新入组成年患者的迁移途径与艾滋病关怀连续性

2026-09-120
OA
Gut-heart immuno-metabolic disruption associated with inflammaging and subclinical coronary artery disease in people with HIV on antiretroviral therapy

HIV感染者中与慢性炎症和亚临床冠状动脉疾病相关的肠道-心脏免疫代谢紊乱

2026-04-270
OAAI
Distinct Gut Microbiota Signatures Are Associated with Severity of Metabolic Dysfunction-Associated Steatotic Liver Disease in People with HIV

HIV感染者中,独特的肠道微生物群特征与代谢功能障碍相关脂肪性肝病的严重程度相关。

2026-03-030
OAAI
Fecal microbiota transplantation to reduce immune activation in ART-treated people with HIV with low CD4/CD8 ratio: protocol for the single-blind, randomized, placebo-controlled Gutsy study (CIHR/CTN PT038)

粪菌移植以降低接受抗逆转录病毒治疗且CD4/CD8比率低的人类免疫缺陷病毒感染者免疫激活:Gutsy研究(CIHR/CTN PT038)单盲、随机、安慰剂对照试验方案

2025-12-130
PRE
Impact of Oral Cannabinoids on the Endocannabinoidome and Gut Microbiome in People with HIV on Antiretroviral Therapy (CTN PT028 Pilot Clinical Trial)

口服大麻素对接受抗逆转录病毒治疗的人类免疫缺陷病毒感染者内源大麻素组学和肠道微生物组的影响(CTN PT028 小型临床试验)

2025-08-290
PRE
Altered memory CCR6+
2024-09-010
OAAI
Material deprivation is associated with liver stiffness and liver-related outcomes in people with HIV
2024-07-160
OAAI
Feasibility of a Randomized, Interventional Pilot Clinical Study of Oral Cannabinoids in People with HIV on Antiretroviral Therapy: CTNPT 028
2024-07-130
OA
Coronavirus disease 2019 outcomes in a population-based cohort of people with HIV and a matched cohort of people without HIV during Omicron variant waves

在Omicron变体波期间,基于人群的HIV感染者队列和匹配的非HIV感染者队列的冠状病毒疾病2019结果

AIDS
IF3.1
2024-07-110
OAAI